Leena Shah

Learning Stage

LEENA SHAH Pharm.D. is global program leader, global drug development at Bristol Myers Squibb. Shah oversees a matrix team, develops and executes a strategic integrated development plan in partnership with cross-functional leaders for early- and late-stage immunology assets across multiple indications. In this role, Shah serves as an integrated, end-to-end leader from drug development to successful launch and commercialization. Shah has 25 years of global development expertise and joined BMS in 2014. At BMS, Shah was an Executive Director in Worldwide Oncology Strategy, led cross-functional teams partnering with research & early development, clinical development, commercial, medical and business development in the creation of tumor strategies across multiple assets. Shah completed the Rutgers Post-Doctoral Fellowship Program in clinical research and earned her BS and doctor of pharmacy from Rutgers, The State University of New Jersey. Shah is most notably recognized for her expertise in drug development, strategic thinking, innovative approaches, and inclusive leadership.